|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 22, 2017 ) According to the report Europe Prostate Cancer Market published by Market Data Forecast, the European market was worth $13.92 billion in 2016 and is projected to reach $21.52 billion with CAGR of 9.1% by 2021
For full report refer to http://www.marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/request-sample
Prostate cancer is an abnormal and uncontrolled growth of cells in prostate gland of a male individual. Majority of prostate cancers are developed sporadically in which genetic changes occur after birth. Although, cause of the prostate cancer is largely unknown, some of the prime factors associated with the disease include obesity, overweight and past history of certain cancers. A person with cardiovascular disease is more prone to advanced metastatic cancer.
Increasing number of people diagnosed with prostate cancer, geriatric population base, demand for novel drugs and unmet conditions are the driving force behind the growth of the market.
Many big shots have collaborated with each other to gain the maximum profit in the forecast period. Government providing funding to public and private funding are also helpful in growth of the market.
Enquire more about the report at http://www.marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/inquire
Segmentation
By Diagnostic Technique
Digital Rectal Exam.
Prostate Specific Antigen Test.
By Radiation Therapy
External Beam Radiation Therapy.
3D Conformal Radiation Therapy.
Intensity Modulated Radiation Therapy.
Stereotactic Body Radiation Therapy.
Proton Beam Radiation Therapy.
Brachytherapy.
Temporary Brachytherapy.
Permanent Brachytherapy.
By Chemotherapy
Docetaxel.
Etoposide.
Vinblastine.
Carboplatin.
Vinorelbine.
By Surgery
Radical Prostatectomy.
Orchidectomy.
Trans Urethral Resection.
By Geography
U.K.
Germany
Italy
Spain
France
Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc.
Buy now at https://www.marketdataforecast.com/cart/buy-now/europe-prostate-cancer-market-1618
The European Prostate Cancer Market study offers following deliverables:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout other related studies in the Therapeutics Segment:
Global Autoimmune Monoclonal Antibodies: http://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/
Global Cancer Immunotherapy Market: http://www.marketdataforecast.com/market-reports/global-cancer-immunotherapy-market-1412/
Global Cancer Vaccine Market: http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/
Global Cervical Cancer Therapeutics and Diagnostic Market: http://www.marketdataforecast.com/market-reports/global-cervical-cancer-diagnostics-and-therapeutics-market-829/
Global Colorectal Cancer Market: http://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/
Global Liver Cancer Therapeutic: http://www.marketdataforecast.com/market-reports/global-liver-cancer-therapeutics-market-836/
About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
